GlobalReach BI

Congratulations to our Founder & CEO for advancing disruptive innovation in the pharmaceutical industry. She recently shared valuable insights on the latest FDA advancements and the transformative impact of our Open AI-powered SPRING Platform on augmenting clinical intelligence in the #pharma #ecosystem. These developments underscore our commitment to pioneering solutions that assist pharma companies in realizing their digital strategy and promote precision pharma. By integrating cutting-edge technologies and staying abreast of regulatory progress, we are poised to lead the industry toward more efficient and effective outcomes. You are invited to enjoy a few brief clips from her recent appearences. https://lnkd.in/eYgDBBK4 https://lnkd.in/eQCRfray #innovation #technology #digital #strategy #business #consulting #mergersandacquisitions #investing #venturecapital #clinicalintelligence #ai #pharma #drugdiscovery #drugdevelopment #researchanddevelopment

Please join us in congratulating our Founder & CEO Yamina Hakem for her recent participation as a guest speaker in a webinar hosted by The Institute for Science, Entrepreneurship and Investment. This "Disruptive by Design "webinar was dedicated to highlighting how the latest Noble Prize Awards and deep tech innovations are transforming the pharma industry and life sciences. Now you can enjoy a brief clip from her valuable contribution. https://lnkd.in/eQCRfray #technology #innovation #pharma #strategy #business #intelligence

Our Founder and CEO Yamina Hakem recently shared her insights about her journey with #FrenchTech. As an Ambassador for French Tech #SanFrancisco and now with French Tech Clermont-Ferrand, she reflects on the incredible experiences that have shaped her entrepreneurial path. Based in the heart of #SiliconValley, she highlights how this dynamic #ecosystem fosters technology, innovation, and collaboration. She emphasizes the importance of networking and stepping out of one’s comfort zone in this fast-paced environment. “I’ve been part of French Tech SF almost since I arrived in San Francisco. The discussions and panels are always enriching as we learn from one another. Every entrepreneur goes through similar stages, and implementing ideas that save time is crucial. I also learned in San Francisco that 'Your network is your net worth,' so expanding your network and stepping out of your comfort zone is key." Check out the YouTube interview to hear more about her inspiring journey! ??????? https://lnkd.in/evHaYZAf #leadership #innovation #technology #entrepreneurship #business #digitalmarketing

As highlighted by our Founder & CEO Yamina Hakem in a recent post, the 2024 Nobel Prize in Chemistry has underscored the impact of novel scientific and deep tech advances on pharma research and development. https://lnkd.in/efnupxeR The combined 2024 Nobel Prize Awards in Chemistry, Physics, Physiology or Medicine mark a pivotal moment for the pharmaceutical industry, emphasizing the urgent need for pharma companies to revise their digital strategies. The integration of artificial intelligence, molecular biology, and complex systems is reshaping the landscape of drug discovery and development. In Physics, the advancements in neural networks by Hopfield and Hinton significantly enhance AI's role in precision medicine, enabling more targeted and effective therapies. In Chemistry, the breakthroughs achieved by Baker, Hassabis, and Jumper in protein structure prediction present revolutionary opportunities for drug discovery, allowing for faster and more efficient identification of potential drug candidates. Meanwhile, the discoveries of microRNA by Ambros and Ruvkun are transforming disease prevention and therapeutic strategies, steering the industry toward personalized medicine and early disease detection. These scientific and technological advancements signal a shift in how pharmaceutical companies will leverage the novel clinical intelligence generated. By revisiting and updating their digital strategies, pharma can capitalize on these breakthroughs to increase their impact, ROI and ultimately enhancing human health on an unprecedented scale. Our AI powered SPRING platform leverages the latest clinical intelligence and can revolutionize the competitive pharma landscape. #innovation #business #strategy #leadership #pharma #intelligence #marketing

Forward-thinking leaders in the pharmaceutical industry must recognize the significance of the 2024 Nobel Prize in Chemistry, as it heralds a new era of #pharma #innovation. The advancements in protein structure prediction and design, driven by AI models like AlphaFold2, signal a transformation in drug discovery and development. Pharma leaders who capitalize on these breakthroughs will accelerate their research and development, as well as their commercialization strategy. GlobalReach BI under the leadership of Yamina Hakem, is at the forefront of this shift. By working with pharma customers and strategic partners, we are leveraging the capabilities of our AI-powered SPRING Platform to provide cutting-edge clinical intelligence insights that harness the latest pharma innovations, driving increased ROI and ensuring competitive advantage. You are invited to read our Founder and CEO’s latest post https://lnkd.in/efnupxeR #pharma #innovation #science #strategy #business #consulting #marketing

We are thrilled to announce that GlobalReach BI attended Pharma CI Conference and Exhibit- one of the Largest Assembly of Competitive Intelligence Executives in Pharma, Biotech, and Medical Devices for 15+ Years. This premier gathering addressed the most pressing and relevant issues facing the competitive intelligence community today. It is considered the golden standard for senior level pharma, biotech, and device professionals. Our Founder and CEO, Yamina Hakem delivered an outstanding presentation on the latest updates to our innovative AI-powered SPRING Platform. During the event, she also proudly announced our recent partnership with BioMinds Advisors, a strategic collaboration that will augment our value proposition. https://lnkd.in/eXuWJyb3 #innovation #transformation #pharma #lifesciences #marketing #digital #technology #leadership #strategy

You are invited to enjoy an insightful video interview with our Founder and CEO Yamina Hakem She shines a spotlight on our company's recent accomplishments and the significant influence of #AI in the pharmaceutical and life insurance sectors. Don't miss out on this inspiring discussion touching on #womenleadership #career #golf #coachella and others. https://lnkd.in/epNuMWGQ #marketing #digitalmarketing #interview #TV #media

Deep tech has had a profound impact on the pharmaceutical and life sciences industries, revolutionizing the way research is conducted, drugs are developed, and patients are treated. At the forefront of this technological revolution is #artificialintelligence (AI), which has transformed all domains within the #pharma #ecosystem. AI has enabled faster #drugdiscovery, #personalizedmedicine, improved patient outcomes, and enhanced operational efficiencies. Forward-thinking business leaders in the pharmaceutical industry must revise their enterprise #digitalstrategy to embed AI in their operational workflows in order to remain competitive in this rapidly evolving landscape. Our founder and CEO Yamina Hakem has been advocating advancements of pharma innovations at various prestigious events this year, including J.P. Morgan Health 2024 Viva Technology 2024 and the ongoing ASCO 2024 meeting. She was also invited as a guest speaker to share the latest trends, challenges, and opportunities of AI in pharma at a series of event dedicated to the AI Revolution. She was joined by other global leaders including Efi Pylarinou Dr. Martha Boeckenfeld Tony Moroney Jo?o Bocas Birgul COTELLI, Ph. D. Kaouthar Lbiati, MD Arijit Chatterjee Lana Feng, Ph.D. You are invited to enjoy highlights from these events in the comments section. She also had the opportunity to showcase how our OpenAI-powered SPRING platform can augment pharma enterprise efforts to gain vital strategic intelligence and maintain a competitive edge in this deep tech-powered era. https://lnkd.in/e5kTrP69

Please join me in congratulating our Founder & CEO Yamina Hakem for her recent contributions as a guest speaker during a thought leadership event. She underscored the profound role of #AI across all industries, with an emphasis on the #pharma industry, and shared latest capabilities of our SPRING-the OpenAI enabled platform implemented by GlobalReach BI. Her brilliant insights complemented recent reports published by EY, Deloitte, PwC, KPMG, Boston Consulting Group (BCG) and others about the profound disruptive role of AI in all pharma life cycle domains. #business #consulting #strategy #economy #marketing #digitalmarketing https://lnkd.in/eqFex7wc

We are thrilled to share that our Founder & CEO, Yamina Hakem was a guest speaker at a recent thought leadership event dedicated to the profound global transformative role of AI. She highlighted the transformative impact of #AI on the #pharmaceutical industry and introduced the latest features of SPRING, our OpenAI-enabled platform. Yamina’s insights are continuing to drive innovation and excellence in pharma and life sciences, complementing prestigious publications like Bain & Company and latest news by the FDA. https://lnkd.in/ejiMWZGa https://lnkd.in/ek2gXZpa #AI #PharmaTech #Leadership #Innovation https://lnkd.in/gt8Ni78q